Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Novadiscovery
Novadiscovery helps drug developers predict clinical trial outcomes and optimize study designs using virtual patients, reducing risk and cost before human testing. The company provides jinkō, an in…
Novadiscovery
Novadiscovery helps drug developers predict clinical trial outcomes and optimize study designs using virtual patients, reducing risk and cost before human testing. The company provides jinkō, an in…
TL;DR
Core offering: In silico clinical-trial simulation platform (JINKO) for predicting outcomes and optimizing trial design
Headquarters: Lyon, France (with a reported New York office)
Founding year: 2010
Business model: B2B SaaS serving pharma, biotech, academic and not-for-profit R&D
Notable investor: Sanofi (led Series A)
Company Overview
Problem Domain
Drug development — clinical trial design and prediction of clinical outcomes
Founded
2010
Industry
Biotechnology
Tech Stack
Funding Track Record
Series A financing cited as led by Sanofi; Crunchbase records indicate multiple funding rounds (total rounds reported as four).
Investor Signal
“Includes strategic biopharma investor participation (Sanofi; Debiopharm Group listed among investors)”